Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Harries

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Autoimmunity Reviews|January 9, 2023
The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reportsAmmara Masood, Amanda Mootoo, Panayiotis Maghsoudlou, et al.
BMJ (Clinical Research Ed.)|February 8, 2013
Call for a balanced view on sentinel node biopsy for melanomaJenny L C Geh, Ciaran Healy, Katie Lacy, et al.
Radiology|March 25, 2014
Changes in primary breast cancer heterogeneity may augment midtreatment MR imaging assessment of response to neoadjuvant chemotherapyJyoti Parikh, Mariyah Selmi, Geoff Charles-Edwards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2011
A phase 1 study of AS1409, a novel antibody-cytokine fusion protein, in patients with malignant melanoma or renal cell carcinomaSarah M Rudman, Michael B Jameson, Mark J McKeage, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2018
Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [<sup>18</sup>F] fluorodeoxyglucose and [<sup>18</sup>F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imagingGurdip K Azad, Benjamin P Taylor, Adrian Green, et al.
Breast (Edinburgh, Scotland)|January 26, 2020
Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup - the "ATRESS" phenomenonPatriek Jurrius, Thomas Green, Hans Garmo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 7, 2003
Capsazepine protects against neuronal injury caused by oxygen glucose deprivation by inhibiting I(h)Alison M Ray, Ceri D Benham, Jenny C Roberts, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2006
A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancerHugo E R Ford, Yoon-Sim Yap, David W Miles, et al.
International Journal of Clinical Practice|May 17, 2017
Treatment patterns and outcomes of Stage IIIB/IIIC melanoma in France, Germany and the UK: A retrospective and prospective observational study (MELABIS)Mark Harries, Peter Mohr, Florent Grange, et al.
Melanoma Research|August 12, 2017
Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study)Florent Grange, Peter Mohr, Mark Harries, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Autoimmunity Reviews|January 9, 2023
The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reportsAmmara Masood, Amanda Mootoo, Panayiotis Maghsoudlou, et al.
BMJ (Clinical Research Ed.)|February 8, 2013
Call for a balanced view on sentinel node biopsy for melanomaJenny L C Geh, Ciaran Healy, Katie Lacy, et al.
Radiology|March 25, 2014
Changes in primary breast cancer heterogeneity may augment midtreatment MR imaging assessment of response to neoadjuvant chemotherapyJyoti Parikh, Mariyah Selmi, Geoff Charles-Edwards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2011
A phase 1 study of AS1409, a novel antibody-cytokine fusion protein, in patients with malignant melanoma or renal cell carcinomaSarah M Rudman, Michael B Jameson, Mark J McKeage, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2018
Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [<sup>18</sup>F] fluorodeoxyglucose and [<sup>18</sup>F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imagingGurdip K Azad, Benjamin P Taylor, Adrian Green, et al.
Breast (Edinburgh, Scotland)|January 26, 2020
Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup - the "ATRESS" phenomenonPatriek Jurrius, Thomas Green, Hans Garmo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 7, 2003
Capsazepine protects against neuronal injury caused by oxygen glucose deprivation by inhibiting I(h)Alison M Ray, Ceri D Benham, Jenny C Roberts, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2006
A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancerHugo E R Ford, Yoon-Sim Yap, David W Miles, et al.
International Journal of Clinical Practice|May 17, 2017
Treatment patterns and outcomes of Stage IIIB/IIIC melanoma in France, Germany and the UK: A retrospective and prospective observational study (MELABIS)Mark Harries, Peter Mohr, Florent Grange, et al.
Melanoma Research|August 12, 2017
Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study)Florent Grange, Peter Mohr, Mark Harries, et al.
Pageof 6